Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil

Psychopharmacology

Volumn 126, Issue 4, 1996, Pages 286-292

  Gold, Lisa H ^a,b   Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Amphetamine; Cocaine; Drug discrimination; Ephedrine; Modafinil; Rat; Rhesus monkey; Self administration

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; COCAINE; DEXAMPHETAMINE; EPHEDRINE; MODAFINIL; PRAZOSIN; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RHESUS MONKEY;

EID: 0029822795     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247379     Document Type: Article

References (41)

1. Akaoka H, Roussel B, Lin J, Chouvet G, Jouvet M (1991) Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci Lett 123: 20-22
2. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4: 69-79
3. Balster RL (1991) Drug abuse potential evaluation in animals. Br J Addict 86: 1549-1558
4. Balster RL, Schuster CR (1973) A comparison of d-amphetamine, l-amphetamine and methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 1: 67-71
5. Balster RL, Woolverton WL (1982) Intravenous buspirone self-administration in rhesus monkeys. J Clin Psychiatry 43: 34-37
6. Balster RL, Carroll FI, Graham JH, Mansbach RS, Rahman A, Lewin AH, Showalter VM (1991) Potent substituted-β-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effects. Drug Alcohol Depend 29: 145-151
7. Bastuji H, Jouvet M (1988) Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 12: 695-700
8. Beardsley PM, Balster RL, Harris LS (1986) Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 18: 149-157
9. Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S (1993) Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol 16: 46-53
10. Bruno A, Nolte KB, Chapin J (1993) Stroke associated with ephedrine use. Neurology 43: 1313-1316
11. Carney JM, Uwaydah IM, Balster RL (1977) Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol Biochem Behav 7: 357-364
12. Chait LD (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 113: 381-387
13. Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacology 16: 30-43
14. 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur J Pharmacol 180: 49-58
15. Fischman MW, Schuster CR, Resnekov L, Shick JFE, Krasnegor NA, Fennell W, Freedivum DX (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33: 983-989
16. Fuxe K, Janson AM, Rosen L, Finnman U-B, Tanganelli S, Morari M, Goldstein M, Agnati LF (1992) Evidence for protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp Brain Res 88: 117-130
17. Gauvin DV, Harland RD, Michaelis RC, Holloway FA (1989) Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. Life Sci 44: 67-73
18. Gauvin DV, Moore KR, Youngblood BD, Holloway FA (1993) The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations. Psychopharmacology 110: 309-319
19. Hermant J-F, Rambert FA, Duteil J (1991) Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after actite and repeated administration. Psychopharmacology 103: 28-32
20. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to abuse liability. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modern methods in pharmacology, vol. 6. Wiley-Liss, New York, pp 193-210
21. Huang J, Ho BT (1974) Discriminative stimulus properties of d-amphetamine and related compounds in rats. Pharmacol Biochem Behav 2: 669-673
22. Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkey. Bull Narc 30: 43-54
23. Kamien JB, Woolverton WL (1989) A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 248: 938-946
24. Lagarde D, Milhaud C (1990) Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep 13: 441-448
25. Lamb RJ, Griffiths RR (1990) Self-administration in baboons and the discriminative stimulus effects in rats of bupropion. nomifensine, diclofensine and imipramine. Psychopharmacology 102: 183-190
26. Lin JS, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591: 319-326
27. Mansbach RS, Balster RL (1993) Effects of mazindol on behaviors maintained or occasioned by cocaine. Drug Alcohol Depend 31: 183-191
28. Mansbach RS, Sannerud CA, Griffiths RR, Balster RL, Harris LS (1990) Intravenous self-administration of 4-methylaminorex in primates. Drug Alcohol Depend 26: 137-144
29. Martin WR, Sloan MD, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245-258
30. Mignot E, Nishino S, Guilleminault C, Dement WC (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17: 436-437
31. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack I (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4: 212-218
32. Rambert FA, Pessonnier J, Duteil J (1990) Modafinil, amphetamine and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 183: 455-456
33. Simon P, Panissaud C, Costentin J (1994) The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology 114: 597-600
34. Snoddy AM, Tessel RE (1983) Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19: 205-210
35. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270: 1041-1048
36. Touret M, Sallanon-Moulin M, Jouvet M (1995) Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 189: 43-46
37. Ueki A, Rosen L, Agnati LF, Hallstrom A, Goiny M, Tanganelli S, Ungerstedt U, Fuxe K (1993a) Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat. Exp Brain Res 96: 89-99
38. Ueki A, Rosen L, Andbjer B, Finnman U-B, Altamimi U, Janson AM, Goldstein M, Agnati LF, Fuxe K (1993b) The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway. Exp Brain Res 93: 259-270
39. Woodward JJ, Mansbach RS, Carroll FI, Balster RL (1991) Cocaethylene inhibits dopamine uptake and produces cocaine-like actions in drug discrimination studies. Eur J Pharmacol 197: 235-236
40. Woolverton WL (1991) Discriminative stimulus effects of cocaine. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph Series 116. DHHS Publication number (ADM)92-1878, pp 61-74
41. Woolverton WL, Nader MA (1990) Experimental evaluation of the reinforcing effects of drugs. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modern methods in pharmacology, vol. 6. Wiley-Liss, New York, pp 165-192